Page last updated: 2024-12-05

dixanthogen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10404
CHEMBL ID331743
CHEBI ID82241
SCHEMBL ID37053
MeSH IDM0040198

Synonyms (111)

Synonym
dixanthogene
dixanthogenum
di-ethoxythiokarbonyl-disulfid
unii-rn4cq46fdm
thioperoxydicarbonic acid (((ho)c(s))2s2), oc,oc'-diethyl ester
4-03-00-00416 (beilstein handbook reference)
dixantogeno
rn4cq46fdm ,
thioperoxydicarbonic acid (((ho)c(s)s)2), diethyl ester
dixanthogen [inn:dcf]
formic acid, dithiobis(thio-, o,o-diethyl ester
einecs 207-944-4
ai3-01649
o,o-diethyl dithiobis(thioformate)
o,o-diethyl ester of dithiobis(thioformic acid)
caswell no. 338
diethyl dixanthogen
diethyl dithiobis(thionoformate)
bis(ethylxanthic) disulfide
thioperoxydicarbonic acid diethyl ester
dixanthogenum [inn-latin]
dixantogeno [inn-latin]
nsc 402561
thioperoxydicarbonic acid (((ho)c(s))2s2), diethyl ester
bisethylxanthogen disulfide
skabilan
dixanthogene [inn-french]
di-ethoxythiokarbonyl-disulfid [czech]
epa pesticide chemical code 086501
brn 1781595
herbisan #5
antigal (van)
dixanthogen (inn)
D07366
bis(ethylxanthic)disulfide
auligen
o,o-diethyl ester of dithiobis[thioformic acid]
aulinogen
dithiobis(thioformic acid) o,o-diethyl ester
dixanthogen
diethyldithiobis thionoformate
herbisan
wln: suyo2&ssyus&o2
herbisan 5
bexide
xanthogen, bis(ethyl-
diethylxanthic disulfide
dixan
scabicidol
bisethylxanthic disulfide
diethyl dixanthogenate
silfasan
EXD ,
diethyl xanthogenate
bisethylxanthogen
o,o-diethyl dithiobis[thioformate]
diethyldithio bis(thionoformate)
ethylxanthogen disulfide
galasan
lenisarin
bis(ethylxanthogen)
k preparation
ethyl xanthogen disulfide
diethylxanthogen disulfide
thioperoxydicarbonic acid, diethyl ester
nsc-402561
xantoscabin
thioperoxydicarbonic acid ([(ho)c(s)]2s2), diethyl ester
preparation k
nsc402561
502-55-6
o-ethyl (ethoxycarbothioyldisulfanyl)methanethioate
1,1'-{dithiobis[(thioxomethylene)oxy]}diethane
NCGC00160587-01
CHEMBL331743
diexanthogen
chebi:82241 ,
diethyldixanthogen
C19120
cas-502-55-6
dtxsid2041672 ,
NCGC00255506-01
tox21_302227
dtxcid0021672
tox21_111916
AKOS024333295
ethoxy[(ethoxymethanethioyl)disulfanyl]methanethione
FT-0603428
o,o-diethyl dithiobis(thionoformate)
dixanthogen [who-dd]
dixanthogen [mi]
dixanthogen [inn]
CCG-213902
SCHEMBL37053
CS-4795
Q-201494
bis[ethylxanthogen]
bext (salt/mix)
formic acid, dithiobis[thio-, o,o-diethyl ester
ethylxanthic disulfide
FVIGODVHAVLZOO-UHFFFAOYSA-N
diethyl dithiobis(thiono formate)
HY-B1186
AB01563210_01
o,o-diethyl dithiobis-(thioformate)
Q5284770
diethyldithiobis(thionoformate)
DB13712
F85253
MS-23434
[[ethoxy(sulfanylidene)methyl]disulfanyl]methanethioic acid o-ethyl ester

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
thiocarbonyl compoundAny compound containing the thiocarbonyl group, C=S.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency20.00480.007215.758889.3584AID1224835
phosphopantetheinyl transferaseBacillus subtilisPotency5.62340.141337.9142100.0000AID1490
retinoid X nuclear receptor alphaHomo sapiens (human)Potency7.32650.000817.505159.3239AID1159531
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency0.89130.035520.977089.1251AID504332
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency27.30600.001723.839378.1014AID743083
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency50.11870.354828.065989.1251AID504847
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency28.18380.251215.843239.8107AID504327
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency17.78280.060110.745337.9330AID492961
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID89802Inhibition of HIV-1 replication in a proliferating human T-cell line assayed using an XTT assay.1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
AID89654Inhibition of HIV-1 replication in human T-cell by using XTT assay; Inactive1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-199033 (63.46)18.7374
1990's2 (3.85)18.2507
2000's0 (0.00)29.6817
2010's5 (9.62)24.3611
2020's12 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.16 (24.57)
Research Supply Index4.08 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.72%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other57 (98.28%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]